Cost to Innovate KPI

Cost to Innovate measures the financial resources allocated to developing new products or services, influencing growth and market positioning.

A high cost can signal inefficiencies in the innovation process, while a low cost may indicate underinvestment in future capabilities.

This KPI directly impacts return on investment (ROI) and long-term financial health.

Organizations that effectively manage this metric can improve operational efficiency and enhance strategic alignment with market demands.

By tracking this KPI, companies can make data-driven decisions that foster innovation and drive sustainable business outcomes.

How Cost to Innovate Connects to Your Strategy

Cost to Innovate ranks fifth among the forty-nine metrics in KPI Depot's Innovation Investment ROI KPI group. That places it firmly in the lead set, and it arrives there as the odd one out.

Look at what surrounds it. Above it sit Return on Innovation Investment, Innovation Pipeline ROI, Innovation-Driven Growth Rate, and Revenue Growth from New Products. Below it sit Break-even Time for Innovation Investments, Time to Profitability, and Profit Margin Impact from Innovation. Every one of those describes what innovation returns or how fast it returns it. Cost to Innovate is the only metric in the top eight that describes what innovation consumes. It is the term the metrics around it divide by or subtract, which is an unusual position for a metric that also gets reported on its own.

Its balanced scorecard placement is the financial perspective, and that placement hides something the KPI group's ordering does not. The financial perspective is normally where outcomes land after the fact. This metric is assembled from two periods that never met: the spend in the numerator is current, and the innovations in the denominator were funded by money committed years earlier. It looks like a lagging financial measure and it behaves like a ratio between two unrelated cohorts.

The first tension is with Return on Innovation Investment and Innovation Pipeline ROI, the two metrics ranked immediately above it. Cost sits inside the denominator of both. Cut spending and both improve arithmetically, with no change in how well anything was invented, built, or sold. Worse, the cut lands first on whatever spend is easiest to stop, which is exploratory work that has no revenue attached to defend it. A KPI group whose top two metrics can be improved by reducing its fifth-ranked metric has a built-in incentive that only explicit sequencing will contain.

The second tension is with Break-even Time for Innovation Investments and Time to Profitability, ranked sixth and seventh, and the KPI group says this one out loud. Its own OKR guidance pairs Cost to Innovate with Time to Profitability and warns that pressing too hard on cost stalls the pipeline while ignoring speed pushes return timelines out. That warning has a mechanism behind it. Speed is almost always purchased: parallel development tracks, additional teams, external partners, tooling, prototyping capacity, expedited supply. Cost to Innovate absorbs every one of those purchases while the velocity metrics collect the benefit. Run the two on separate objectives owned by separate people and each side wins by damaging the other's number.

The third tension is inside the metric rather than between metrics, and it reaches the KPI group through the denominator. Cost to Innovate divides spend by the number of innovations developed, and nothing anywhere defines what one innovation is. The quickest way to improve the figure is to develop more, smaller things and classify all of them as innovations. A portfolio of incremental feature work produces a very attractive cost per innovation. Meanwhile Innovation-Driven Growth Rate and Revenue Growth from New Products, ranked third and fourth, are eventually paid for by the substantial programs a per-unit cost metric penalizes, since those consume for years before producing a single countable output. The KPI group's own material points the same way when it argues for tracking commercialization rather than idea volume. The advice applies just as hard to the denominator of this metric as it does to funnel counts.

Measuring Cost to Innovate in Practice

The formula divides total expenditure on innovation activities by the total number of innovations developed. Neither term has an agreed definition, and the definitions a customer chooses will change the answer by more than any efficiency initiative ever will.

What Counts as Innovation Spend. The boundary against ordinary product development, sustaining engineering, maintenance, customer-specific work, and regulatory compliance work is the first decision and the least examined. Two ready-made boundaries exist and both were drawn for other purposes. Accounting rules separate research from development for the purpose of financial statements. Research incentive regimes define qualifying expenditure for the purpose of tax relief. Each excludes things innovation leaders consider central, such as customer and market research, business model design, service design, pilots, partnership development, and commercial launch. Each includes things they would not, such as routine product upkeep that happens to satisfy a technical uncertainty test. Borrowing either boundary is defensible. Borrowing one silently is not, because the resulting figure will not match how the organization talks about innovation in any other room.

Capitalized Against Expensed. Where development costs are capitalized, the spend leaves the expense line and returns later as amortization. A numerator built from the profit and loss statement therefore omits exactly the projects that progressed far enough to qualify for capitalization, which tend to be the largest ones. Two organizations doing identical work under different capitalization policies report different costs to innovate and neither is wrong. A policy change inside one organization breaks its own series with no change in activity at all. Decide whether the numerator is cash committed, expense recognized, or total project cost regardless of accounting treatment, and restate the history whenever that decision moves.

Failures Belong in the Numerator. This is the single largest driver of the figure and the one most often quietly resolved in the flattering direction. If only the costs of innovations that survived are counted, the metric reports the cost of the survivors and calls it the cost of innovating. The real cost of one commercialized innovation includes every project killed on the way there, which is the entire reason a portfolio exists. A portfolio-level numerator over a commercialized-output denominator is the honest construction and it produces a much larger figure than the project-level version. Both constructions are legitimate and they answer different questions. What is never legitimate is a numerator that drops terminated projects while the denominator counts only winners, because that is a cost per success computed with none of the cost of failure in it.

Allocated Overhead. Facilities, information technology, legal and intellectual property, procurement, finance support, executive attention, shared laboratory and test capacity. A direct-cost figure is reproducible and understates reality. A fully loaded figure is closer to the truth and it moves whenever finance revises an allocation rate, for reasons entirely unrelated to innovation. Allocation rates get rewritten during reorganizations and budget cycles, so the series will step and nobody will know why unless rate changes are logged beside it. Publish the basis, because a direct figure and a loaded figure are not comparable and nothing in the number reveals which one is on the page.

Staff Time Is the Biggest Estimate in the Number. For most organizations people are the majority of innovation spend, and almost nobody measures their time directly. It arrives through self-reported timesheets, project codes chosen under deadline pressure, or an allocation percentage agreed once a year and never revisited. Engineers split between new work and keeping existing products alive classify the split according to what they believe the data is used for, and that classification shifts the moment the metric becomes a target. Then there is the rate: actual salary cost, a standard blended rate, or a fully loaded rate are three different answers. Moving work between employees, contractors, and agencies changes the cost without changing the effort by a minute.

Money That Comes from Outside. Grants, tax credits, co-funded consortium work, customer-funded development, and partner contributions all reduce net spend. Gross and net numerators are both in use and they are rarely labelled. Credits recognized in a later period against spend incurred earlier will not land in the same year as the cost they offset, which puts a second timing error inside the numerator. Separately, innovation that is bought rather than built, through licensing, acquisitions, university programs, or corporate venture stakes, is spend on innovation under any ordinary reading and sits outside the research line in most ledgers. Decide whether it is in, and say so.

What Is an Innovation. The denominator has no natural unit. The candidates are ideas accepted into the funnel, projects started, projects passing a stage gate, patents filed or granted, products launched, features shipped, and new offerings that produced revenue. Count features and the cost per innovation is small and says nothing. Count platform launches and it is large and swings violently from year to year. Then the recognition point has to be set: developed, launched, or commercially proven. There is also a distribution problem underneath all of this. Innovation portfolios are severely uneven, a few programs consume most of the money, and a mean cost per innovation is therefore dominated by those few and describes none of the individual items. Report a median beside the mean, or segment by horizon before averaging, or the average is decoration.

The Timing Mismatch. This is the structural flaw and no definition fixes it. Current spend funds innovations that will appear years from now, while the innovations counted this period were funded by money committed before. The ratio pairs two cohorts that have nothing to do with each other. It improves in a year when spending is cut and an earlier investment happens to be harvested. It deteriorates at the start of any serious new program, which is the signal inverted. The sound construction is cohort accounting: follow a vintage of spend through to the outputs that vintage produced, which requires a project ledger that persists across years rather than an annual total. A fixed lag applied to the denominator is the cheap approximation. The lag is a guess, so state it and hold it constant.

What the Metric Punishes. All of the above compounds into one behavior. Cost per innovation improves by spending less, by counting more things, and by avoiding anything with a long or uncertain payoff. Exploratory research appears in the numerator for years and in the denominator possibly never. A team managed on this number cuts exploration first, because it is the only spend with nothing yet to defend it. The metric is genuinely useful as a constraint and as a diagnostic of where money goes. Set as a target on its own, it selects against the work it exists to support.

Segmentation that makes the figure mean something: by innovation horizon, separating core, adjacent, and transformational work, which is the cut that rescues the average; by stage, so cost per gate is visible instead of one blended number; by business unit; by direct against fully loaded cost; by built against acquired or licensed; by terminated against commercialized; and by geography, since labor rates and incentive regimes differ enough to make a single group figure misleading.

The data is scattered, and that is why most published versions of this metric are unreliable. The general ledger holds spend, but usually by cost center, and a cost center is a department rather than a project. Project or work breakdown codes hold the useful view where they exist and where people use them consistently. Time tracking holds the labor split. Accounts payable and procurement hold external spend, classified by vendor rather than by purpose. The fixed asset ledger holds the capitalized portion and its amortization schedule. Human resources holds the rates. The portfolio management system holds the project list, its stage, and its outcome. The intellectual property system holds patents and the product catalog holds launches. The join that almost never exists is the one between the money and the portfolio: one identifier per project, carried in both the ledger and the portfolio system, from the first charge through to termination or launch. Without it the numerator and the denominator are assembled by different teams from different sources, and the ratio is a comparison of two estimates that were never reconciled to each other.

Expect the internal figure and any externally reported research and development number to disagree, because the external one follows accounting rules and the internal one follows the operating definition. Reconcile them once in writing and keep the reconciliation, because the question gets asked by somebody senior at the worst possible moment.

Common Pitfalls

Many organizations misinterpret the Cost to Innovate, viewing it solely as a budget line item rather than a strategic investment.

• Failing to align innovation spending with business strategy leads to wasted resources. Without a clear connection to strategic goals, innovation efforts may not yield desired outcomes.
• Neglecting to track the effectiveness of innovation initiatives can result in continued investment in unproductive areas. Regular variance analysis is essential to ensure funds are allocated effectively.
• Overemphasizing short-term cost savings can stifle long-term innovation potential. Cutting budgets may seem prudent, but it can hinder the development of future capabilities.
• Ignoring market trends and customer feedback can lead to misaligned innovation efforts. Organizations must remain agile and responsive to evolving demands to maintain relevance.

Improvement Levers

Enhancing the Cost to Innovate requires a strategic focus on efficiency and effectiveness in innovation processes.

• Implement a robust KPI framework to track innovation spending and outcomes. Regular management reporting ensures alignment with strategic objectives and highlights areas for improvement.
• Adopt agile methodologies to streamline innovation processes. This approach fosters rapid prototyping and iterative development, reducing time and costs associated with bringing new products to market.
• Invest in employee training to enhance innovation capabilities. Empowering teams with the right skills can lead to more effective idea generation and execution.
• Utilize data analytics to inform decision-making around innovation investments. Analytical insights can identify high-potential projects and optimize resource allocation.

KPI Depot is trusted by consulting, strategy, finance, and analytics teams at leading organizations worldwide, including those listed below.

Cost to Innovate Benchmarks

We have 1 relevant benchmark in our benchmarks database.

Browse the Top Benchmarked KPIs in Innovation Investment ROI

OKRs That Use Cost to Innovate

Two of the Innovation Investment ROI KPI group's objectives have a genuine place for this KPI, and the KPI group's own best practice guidance names it directly in one of them.

Maximize financial returns from innovation investments through disciplined portfolio management rests on Return on Innovation Investment, Innovation Pipeline ROI, an investment efficiency ratio, and Profit Margin Impact from Innovation. Cost to Innovate sits inside the first three of those as a denominator, which makes it an awkward key result for the same objective: improving it improves the others arithmetically whether or not anything actually got better. Used properly it belongs there as the quality term rather than the volume term. A key result written as lowering fully loaded cost per commercialized innovation, at a fixed definition of both terms and with terminated projects left in the numerator, is a claim about efficiency. A key result written as reducing innovation spend is a claim about the budget, and the objective already has better instruments for that. Say which one is meant, in the key result itself.

Accelerate innovation velocity to capture first-mover advantages in competitive markets puts this KPI to better use. That objective runs on Time to Market, Break-even Time for Innovation Investments, Time to Profitability, and an innovation agility measure, and every one of them can be bought with money. The KPI group's guidance makes the link explicit, pairing Cost to Innovate with Time to Profitability and warning that cutting cost too aggressively stalls the pipeline while ignoring speed pushes returns further out. The right role here is a guardrail rather than a goal: hold cost per innovation flat or improving while the velocity key results move. Framed that way it stops an acceleration program from being funded invisibly, and it stops a cost program from quietly stretching every timeline in the portfolio.

The KPI group's advice on long innovation cycles applies to both framings. Targets on this metric need multi-year horizons with interim milestones tied to agility, because any single year's figure pairs that year's spend against innovations funded before the objective was written. Read literally, an annual key result on this KPI rewards a year in which nothing new was started.

One objective to keep it away from. Boost innovation output quality to improve commercial success and customer impact runs on Innovation Success Rate, a commercialization rate, retention attributed to innovation, and market share growth from innovations. A cost-per-innovation key result under that objective creates a conflict of interest, because the same team then controls the count sitting in this metric's denominator. Cost per innovation drops as soon as more and smaller items are classified as innovations, and the success rate can rise for the same reason. Keep the counting rule owned somewhere other than the team whose key result depends on it.

See OKR Examples for Innovation Investment ROI

Free Whitepaper

Want to achieve performance excellence in Innovation Investment ROI? Download our in-depth whitepaper: Definitive Guide to Innovation Investment ROI KPIs.

Download the Free Guide

KPI Categories

This KPI is associated with the following categories and industries in our KPI database: